Global markets face turbulence from geopolitical tensions and rising oil prices. Venugopal Garre advises investors to adopt a long-term perspective, building portfolios for the next 12 to 24 months. He suggests focusing on sectors that have fallen but are poised for a rebound.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.